vs
Side-by-side financial comparison of ILLUMINA, INC. (ILMN) and 10x Genomics, Inc. (TXG). Click either name above to swap in a different company.
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — | ||
| Q4 23 | $1.1B | — | ||
| Q3 23 | $1.2B | — | ||
| Q2 23 | $1.1B | — |
| Q4 24 | $186.0M | — | ||
| Q3 24 | $705.0M | — | ||
| Q2 24 | $-2.0B | — | ||
| Q1 24 | $-126.0M | — | ||
| Q4 23 | $-754.0M | — | ||
| Q3 23 | $-234.0M | — | ||
| Q2 23 | $3.0M | — |
| Q4 24 | 65.9% | — | ||
| Q3 24 | 69.0% | — | ||
| Q2 24 | 64.8% | — | ||
| Q1 24 | 62.0% | — | ||
| Q4 23 | 61.1% | — | ||
| Q3 23 | 62.2% | — | ||
| Q2 23 | 60.3% | — |
| Q4 24 | 15.8% | — | ||
| Q3 24 | 68.6% | — | ||
| Q2 24 | -147.2% | — | ||
| Q1 24 | -10.3% | — | ||
| Q4 23 | -67.4% | — | ||
| Q3 23 | -7.5% | — | ||
| Q2 23 | -5.9% | — |
| Q4 24 | 16.8% | — | ||
| Q3 24 | 65.3% | — | ||
| Q2 24 | -178.8% | — | ||
| Q1 24 | -11.7% | — | ||
| Q4 23 | -67.4% | — | ||
| Q3 23 | -19.9% | — | ||
| Q2 23 | 0.3% | — |
| Q4 24 | $1.16 | — | ||
| Q3 24 | $4.42 | — | ||
| Q2 24 | $-12.48 | — | ||
| Q1 24 | $-0.79 | — | ||
| Q4 23 | $-4.77 | — | ||
| Q3 23 | $-1.48 | — | ||
| Q2 23 | $0.02 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
